Instituto de Neurobiología UNAM-Juriquilla, Querétaro 76230, Mexico.
Nutrients. 2020 Nov 25;12(12):3613. doi: 10.3390/nu12123613.
Epidemiological studies on micronutrient consumption have reported protective associations in the incidence and/or progression of various cancer types. Supplementation with some of these micronutrients has been analyzed, showing chemoprotection, low toxicity, antiproliferation, and the ability to modify epigenetic signatures in various cancer models. This review investigates the reported effects of micronutrient intake or supplementation in breast cancer progression. A PubMed search was conducted with the keywords "micronutrients breast cancer progression", and the results were analyzed. The selected micronutrients were vitamins (C, D, and E), folic acid, metals (Cu, Fe, Se, and Zn), fatty acids, polyphenols, and iodine. The majority of in vitro models showed antiproliferative, cell-cycle arrest, and antimetastatic effects for almost all the micronutrients analyzed, but these effects do not reflect animal or human studies. Only one clinical trial with vitamin D and one pilot study with molecular iodine showed favorable overall survival and disease-free interval.
关于微量营养素摄入的流行病学研究报告称,其与多种癌症类型的发病和/或进展呈保护相关。对其中一些微量营养素的补充进行了分析,结果显示其具有化学预防作用、低毒性、抗增殖作用,并能够改变各种癌症模型中的表观遗传特征。本综述调查了报道的微量营养素摄入或补充对乳腺癌进展的影响。使用关键词“micronutrients breast cancer progression”在 PubMed 上进行了搜索,并对结果进行了分析。所选的微量营养素包括维生素(C、D 和 E)、叶酸、金属(铜、铁、硒和锌)、脂肪酸、多酚和碘。大多数体外模型显示,几乎所有分析的微量营养素都具有抗增殖、细胞周期停滞和抗转移作用,但这些作用并不能反映动物或人体研究的结果。只有一项维生素 D 的临床试验和一项分子碘的试点研究显示出良好的总生存率和无病间隔。